PROCEPT BioRobotics Corporation
PRCT
$40.52
$1.213.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 48.41% | 55.28% | 56.57% | 66.29% | 61.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 48.41% | 55.28% | 56.57% | 66.29% | 61.17% |
| Cost of Revenue | 25.44% | 28.18% | 10.02% | 32.23% | 49.04% |
| Gross Profit | 64.37% | 76.40% | 105.47% | 95.57% | 70.83% |
| SG&A Expenses | 37.97% | 39.39% | 33.04% | 29.83% | 25.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.43% | 33.82% | 20.25% | 33.08% | 36.53% |
| Operating Income | 17.29% | 0.76% | 33.32% | 12.43% | -4.69% |
| Income Before Tax | 23.60% | 4.70% | 31.44% | 14.82% | -1.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.60% | 4.70% | 31.44% | 14.82% | -1.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.60% | 4.70% | 31.44% | 14.82% | -1.35% |
| EBIT | 17.29% | 0.76% | 33.32% | 12.43% | -4.69% |
| EBITDA | 19.40% | 1.90% | 35.35% | 14.07% | -2.31% |
| EPS Basic | 28.87% | 11.50% | 35.59% | 20.88% | 11.34% |
| Normalized Basic EPS | 28.88% | 11.48% | 35.58% | 20.88% | 11.32% |
| EPS Diluted | 28.87% | 11.50% | 35.59% | 20.88% | 11.34% |
| Normalized Diluted EPS | 28.88% | 11.48% | 35.58% | 20.88% | 11.32% |
| Average Basic Shares Outstanding | 7.41% | 7.66% | 6.42% | 7.66% | 14.31% |
| Average Diluted Shares Outstanding | 7.41% | 7.66% | 6.42% | 7.66% | 14.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |